All Articles tagged survival

• Oncology
  October 27, 2023 EDT
  Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
  Robert L. ColemanJamie GarsideJean HurteauJoehl NguyenMonica Kobayashi

  We describe real-world demographics, clinical characteristics, treatment patterns, and overall survival among US patients with primary advanced or recurrent endometrial cancer who initiated at least 1 line of therapy.

  Abstract
• Oncology
  September 08, 2023 EDT
  Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm
  Scott GouldenQin ShenRobert L. ColemanCara MathewsMatthias HungerAnkit PahwaRene Schade

  This study compared overall survival and described time-to-treatment discontinuation for dostarlimab (GARNET Cohort A1 safety population) with an equivalent real-world external control arm receiving non-anti-programmed death (PD)-1/PD-ligand 1/2 treatments.

  Abstract
• Oncology
  December 09, 2021 EDT
  Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
  Manjusha HurryShazia HassanSoo Jin SeungRyan N. WaltonAshlie ElnoursiJacob D. McGee

  There are few studies reporting current OC costs. This study sought to determine patient characteristics and costs to the health system for OC in Ontario, Canada.

  Abstract
• Hematology
  June 04, 2020 EDT
  JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling
  Jonas HjelmgrenKristoffer NilssonGunnar Birgegård

  We validate an economic model for polycythemia vera that uses Janus Kinase 2 burden as a surrogate endpoint to predict disease progression and overall survival based on progression-specific mortality.

  Abstract
• Methodology and Healthcare Policy
  February 14, 2015 EDT
  A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data
  Gabriel TremblayPatrick HainesAndrew Briggs

  This paper looks at different techniques that can be used to extrapolate trial data, as well as criteria that should be used to select the most appropriate technique.

  Abstract